Skip to main content
. 2017 Dec 28;44(6):1254–1266. doi: 10.1093/schbul/sbx167

Table. 4.

Treatment effects: Secondary Neurocognition, Symptom, and Functioning Measures Across Baseline, Midpoint, and End-point Assessments.

graphic file with name sbx167t02.jpg